Table 1.
Critical miRNAs as potential diagnostic, therapeutic, prognostic targets in PDAC
miRNAs | Function | Expression in tumor | Targets | Pathway | Ref. |
---|---|---|---|---|---|
miR-21 | Oncogenic | Up-regulated | PTEN, PDCD4, CDK6, CDKN1A, IL-6R, FAS, TPM1, APAF1, SOCS5 | PI3K/AKT | [20–22] |
miR-34 | Tumor suppressor | Down-regulated | NOTCH, BCL2, VEGFA, CCND1, CDK6 | p53/p38-MAPK/NOTCH PI3K/AKT | [14, 24, 26] |
miR-200 family | Tumor suppressor | Down-regulated | E-cadherin, ZEB, Vimentin | NOTCH, EMT | [14, 20, 23] |
Let-7 family | Tumor suppressor | Down-regulated | KRAS, HRAS, LIN28, HMGA2, NF2, TRIM71 | EMT, KRAS | [16] |
miR-15a | Tumor suppressor | Down-regulated | WANT3A, FGF7, BMI-1 | ERK/AKT, EMT | [28, 29] |
miR-506 | Tumor suppressor | Down-regulated | SPHK1, PI3M | SPHK1/AKT/NF-κB | [31, 32] |
miR-221 | Oncogenic | Up-regulated | KIT, CDKN1C, CDKN1B | EMT, PKC/NF-κB, PTEN/PI3K/AKT | [14, 21] |
miR-96 | Tumor suppressor | Down-regulated | KRAS, AKT | KRAS, PI3K/AKT | [14, 15] |
miR-17-92 | Tumor suppressor | Down-regulated | p21, p57, TBX3 | NODAL/ACTIVIN/TGF-1 | [18] |
miR-145 | Tumor suppressor | Down-regulated | KRAS, RREB1 | KRAS, PI3K/AKT | [14] |
miR-155 | Oncogenic | Up-Regulated | TP53INP | Apoptosis, Exosome Synthesis | [30] |